Millipore Sigma Vibrant Logo

AGX818 SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen

View Products on Sigmaaldrich.com
AGX818
100 μg  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited Availability
Limited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information
      Description
      Catalogue NumberAGX818
      DescriptionSARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen
      Alternate Names
      • COVID-19
      • 2019-nCoV
      Background InformationCoronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 spike antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).
      References
      Product Information
      FormatPurified
      PresentationPurified in 10mM Phosphate Buffered Saline with 0.09% sodium azide, pH 7.0.
      Quality LevelMQ100
      Applications
      ApplicationCOVID-19 Spike Protein S1 (aa 1-681) Recombinant Antigen, expressed in HEK293 cells, Cat. No. AGX818 is tested for use in ELISA, Lateral Flow Assay as Positive Control.
      Key Applications
      • Positive Control
      • ELISA
      • Immunodiffusion
      Biological Information
      ConcentrationPlease refer to guidance on suggested starting dilutions and/or titers per application and sample type.
      HostHuman Recombinant
      Purification MethodAffinity Chromatography
      UniProt Number
      Molecular Weight76 kDa
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -10°C to -25°C from date of receipt. Avoid repeated freeze/thaw cycles.
      Packaging Information
      Material Size100 μg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalog Number GTIN
      AGX818 04061842605927

      Documentation

      SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen SDS

      Title

      Safety Data Sheet (SDS) 

      SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen Certificates of Analysis

      TitleLot Number
      SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3596269 3596269
      SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3666807 3666807
      SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3674836 3674836
      SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3683143 3683143
      SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3693112 3693112
      SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3706646 3706646
      SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3709543 3709543
      SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3723429 3723429
      SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3756564 3756564
      SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3757092 3757092